Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

BACKGROUND: There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). METHODS: We assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Harmony R., Adhikari, Samrachana, Pulgarin, Claudia, Troxel, Andrea B., Iturrate, Eduardo, Johnson, Stephen B., Hausvater, Anaïs, Newman, Jonathan D., Berger, Jeffrey S., Bangalore, Sripal, Katz, Stuart D., Fishman, Glenn I., Kunichoff, Dennis, Chen, Yu, Ogedegbe, Gbenga, Hochman, Judith S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206932/
https://www.ncbi.nlm.nih.gov/pubmed/32356628
http://dx.doi.org/10.1056/NEJMoa2008975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206932/
https://www.ncbi.nlm.nih.gov/pubmed/32356628
http://dx.doi.org/10.1056/NEJMoa2008975

Ejemplares similares